The first sickle cell disease patient has been enrolled in a Phase 1b trial testing iadademstat, Oryzon Genomics' ...
Fear, anxiety, stress, and burnout can all happen to parents of children with sickle cell disease, writes columnist.
Disc Medicine is planning to launch a trial by year's end to test DISC-3405, its treatment candidate for iron overload, in ...
Invisible Disabilities Week may have passed by unnoticed, but many of us live it every day, writes columnist Mary Shaniqua.
A Phase 1b clinical trial testing pociredir in adults with sickle cell disease has completed enrollment of its high-dose ...
Testing for PlGF levels can predict the risk of early-onset preeclampsia during pregnancy in people with sickle cell disease, ...
Columnist Mary Shaniqua offers up ideas for managing sickle cell disease to get the most out of busy end-of-year events.
Wilson writes that withdrawing has been for him a way to feel safe, but frustrated his ability to connect to others.
The European Medicines Agency has confirmed suspension of marketing authorization for Pfizer's now-withdrawn Oxbryta for sickle cell disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback